News & Updates
The Latest on Internet Pharmacies, Supplements, Designer Drugs,
and Other High-Risk Merchants
HCG: A Long-Lived Diet That’s Short on Evidence
Originally surfacing in the 1950s, the HCG diet has been rising in popularity once again, despite concerns about its safety and efficacy. Short for Human Chorionic Gonadotropin, HCG is a hormone that is produced naturally in the body during pregnancy. The US Food and Drug Administration (FDA) has approved some injectable forms of HCG for…
LegitScript Discounts Telemedicine Certification to Help Providers Meet Surge in Demand
As the pandemic continues to limit access to in-person healthcare services, telemedicine providers play an increasingly important role in providing services such as prescriptions and medical consultations. In response to this surge in demand, LegitScript is currently discounting application fees and first year annual monitoring fees for eligible telemedicine providers who apply for LegitScript certification…
Law and Odor: The Ins and Outs of Terpenes
As the cannabis market becomes increasingly more crowded, companies have been looking for ways to differentiate themselves from the competition. Some turn to novel delivery systems, such as CBD-infused clothes or pillows. Others may sell CBD products that contain psychoactive ingredients, such as kratom. Terpenes are the next attempt to stand out. They now appear…
Romance Scams: A Dangerous Undertow Sweeping Across the Sea of Love
In this digital age, an ever-increasing number of people are seeking love and companionship by venturing into online dating websites, mobile apps, online classified listings, and social media platforms. Unfortunately, the cyber world is also fraught with opportunistic criminals who are looking to prey on the heartstrings of hopeful victims. The Federal Trade Commission recently…
LegitScript Waives Some Certification Fees to Help Telehealth Providers Meet Pandemic Demand
LegitScript’s mission — making the internet and payments ecosystems safer and more transparent — is more important than ever in the midst of the ongoing pandemic related to the novel coronavirus. As you may have read in the media or with our own reporting, there is a lot going on with cybercrime related to the…
How to Spot Donation Scams Related to COVID-19
In the midst of a natural disaster or other large crisis, scammers inevitably take advantage of the spike in public goodwill and the influx of genuine fundraising and charity websites. LegitScript has observed this to be true in the midst of the health and economic impacts of the COVID-19 pandemic. These scammers may pose as…
Bogus Cures and Unapproved Treatments for COVID-19 Flood the Internet
With the COVID-19 pandemic sweeping across the globe, the payments and e-commerce landscapes are especially vulnerable right now to scammers preying on consumers with fake cures, unapproved treatments, and other unconventional products and services to treat the new coronavirus. These scams are not only detrimental to public health but also pose serious risks of chargebacks…
Price Gouging from Coronavirus Opportunists Poses Credit and Regulatory Risk
As the pandemic caused by the novel coronavirus spreads, opportunistic scammers have begun taking advantage of panicked consumers through price gouging on basic healthcare products, such as hand sanitizer, face masks, and toilet paper. Many online merchants are now offering these products at drastic markups, ranging from three small bottles of hand sanitizer for $60…
As Coronavirus Spreads, So Do Fake, Unapproved, and Ineffective Test Kits
LegitScript has been proactively monitoring the online space in response to the outbreak of the virus SARS-CoV-2, which causes COVID-19, and has identified an increasing trend in the marketing of coronavirus-related products that present an elevated risk to consumers, payment service providers, and e-commerce platforms. In particular, the severe shortage of diagnostic kits to test…
New Warning Letters Signal Forceful Approach to Containing Coronavirus Treatment Claims
The Federal Trade Commission (FTC) and US Food and Drug Administration (FDA) announced Monday seven warning letters they issued jointly to business owners making potentially problematic claims that their products can treat or prevent the new coronavirus. These letters appear to reflect aggressive action by the federal agencies to stop businesses capitalizing on COVID-19 fears…
